Should the Start of Immunosuppressive Treatment for COVID-19 Rely upon the Degree of Inflammation or the Time from Onset? by José María Mora-Luján, Abelardo Montero, Francesc Formiga, Manuel Rubio-Rivas

Get full text

Tracing In-Hospital COVID-19 Outcomes: A Multistate Model Exploration (TRACE) by Hamed Mohammadi, Hamid Reza Marateb, Mohammadreza Momenzadeh, Martin Wolkewitz, Manuel Rubio-Rivas

Get full text

Assessing the impact of long-term inhaled corticosteroid therapy on patients with COVID-19 and coexisting chronic lung disease: A multicenter retrospective cohort study by Adela Pina Belmonte, Manuel Madrazo, Laura Piles, Manuel Rubio-Rivas, Lucía de Jorge Huerta, María Gómez Antúnez, Juan Francisco López Caleya, Francisco Arnalich Fernández, Martin Gericó-Aseguinolaza, Paula Maria Pesqueira Fontan, Nicolás Rhyman, Marina Prieto Dehesa, Juan Luis Romero Cabrera, Gema María García García, Gonzalo García-Casasola, Ane Labirua-Iturburu Ruiz, Francisco Javier Carrasco-Sánchez, Sara Martínez Hernández, Maria de los Reyes Pascual Pérez, José López Castro, José Luis Serrano Carrillo de Albornoz, José F. Varona, Ricardo Gómez-Huelgas, Juan-Miguel Antón-Santos, Carlos Lumbreras-Bermejo

Get full text

Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry by Crhistian-Mario Oblitas, Pablo Demelo-Rodríguez, Lucía Barrera-López, Francisco Galeano-Valle, Manuel Rubio-Rivas, Jairo Luque del Pino, Vicente Giner Galvañ, Diana Paredes-Ruíz, Rosa Fernández-Madera Martínez, Martín Gericó Aseguinolaza, Ricardo Gómez-Huelgas, Francisco Arnalich Fernández, José David Torres Peña, José Ignacio Martín González, Manuel Méndez-Bailón, Daniel Monge Monge, Santiago J. Freire Castro, Cruz Pastor Valverde, Enrique Rodilla-Sala, Marcos Guzmán García, María Rivas-Carmenado, César-Manuel Gallo, Marina Amparo Perea Ribis, José-Manuel Casas-Rojo, Jesús Millán Núñez-Cortés, SEMICOVID-19 Network

Get full text